-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HujQfyoCnMhTiofwWontXjSIZFTSeEeaV8Z8abo59/E5NjggdAP9nAw7R+dm+Eyu XZBrVNRgH2ro28nNC5lYZw== 0000950116-05-001383.txt : 20050415 0000950116-05-001383.hdr.sgml : 20050415 20050415162628 ACCESSION NUMBER: 0000950116-05-001383 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050405 FILED AS OF DATE: 20050415 DATE AS OF CHANGE: 20050415 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amanatides Peter CENTRAL INDEX KEY: 0001323564 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 05753989 BUSINESS ADDRESS: BUSINESS PHONE: 514-341-9940 XT 222 MAIL ADDRESS: STREET 1: DSM BIOLOGICS STREET 2: 6000 ROYALMOUNT AVENUE CITY: MONTREAL STATE: A8 ZIP: H4P 2T1 4 1 p405999_ex.xml 4 X0202 4 2005-04-05 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001323564 Amanatides Peter C/O GENEREX BIOTECHNOLOGY CORPORATION 33 HARBOUR SQUARE, SUITE 202 TORONTO A6 M5J2G2 ONTARIO, CANADA 1 0 0 0 Common Stock 2005-08-05 4 P 0 1000 .78 A 1000 D Common Stock Purchase Options .56 2005-04-05 4 A 0 100000 0 A 2005-04-05 2010-04-04 Common Stock 100000 100000 D Peter Amanatides 2005-04-14 -----END PRIVACY-ENHANCED MESSAGE-----